The effect of staurosporine, a protein kinase inhibitor, on asialoglycoprotein receptor endocytosis.
Receptor-mediated endocytosis via coated pits is modulated by the activity of protein kinases and protein phosphorylation. We examined the effects of the potent protein kinase inhibitor staurosporine (SSP) on endocytosis of the asialoglycoprotein (ASGP) receptor in HepG2 cells. Staurosporine caused a rapid (< 2 min) inhibition of ligand internalization from the cell surface. In contrast the rate of receptor exocytosis from intracellular compartments to the cell surface was not altered (t1/2 = 8 min). This resulted in increased ASGP receptors at the plasma membrane (140% of control) while the total number of receptors per cell was unchanged. Receptor up-regulation was half-maximal at 30 nM SSP. At this concentration staurosporine also inhibited the internalization of iodinated transferrin by HepG2 cells and SK Hep-1 cells, another human hepatoma-derived cell line. Staurosporine was without effect on the non-receptor-mediated uptake of Lucifer yellow by pinocytosis. We investigated the possible involvement of protein kinase C in the inhibitory effects of staurosporine on receptor endocytosis. The active protein kinase C inhibitor H7 did not inhibit ASGP receptor internalization. Furthermore depletion of cellular protein kinase C by overnight incubation with 1 microM phorbol myristate acetate did not abrogate the SSP effect. Together these data suggest that the mechanism of SSP action is independent of the inhibition of protein kinase C. In conclusion staurosporine is a potent and rapid inhibitor of receptor trafficking which is specific for receptor internalization from the plasma membrane.
Fallon
R J
RJ
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.
Danaher
M
M
D000470:Alkaloids / Q000494:pharmacology*; D037263:Asialoglycoprotein Receptor; D001212:Asialoglycoproteins / Q000378:metabolism*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D004705:Endocytosis / Q000187:drug effects*; D005089:Exocytosis / Q000187:drug effects; D006801:Humans; D009961:Orosomucoid / Q000031:analogs & derivatives / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D011971:Receptors, Immunologic / Q000378:metabolism*; D011990:Receptors, Transferrin / Q000187:drug effects / Q000378:metabolism; D019311:Staurosporine; D014407:Tumor Cells, Cultured; D015854:Up-Regulation / Q000187:drug effects
D000470:Alkaloids; D037263:Asialoglycoprotein Receptor; D001212:Asialoglycoproteins; D009961:Orosomucoid; D011971:Receptors, Immunologic; D011990:Receptors, Transferrin; C017030:asialoorosomucoid; D011493:Protein Kinase C; D019311:Staurosporine